Yulia Desheva | Immunology | Best Researcher Award

Dr. Yulia Desheva | Immunology | Best Researcher Award

Institute of Experimental Medicine | Russia

Author Profile

Scopus 

Orcid ID

🌟 Biography of Yulia Desheva 🌟

EARLY ACADEMIC PURSUITS 🎓

Yulia Desheva demonstrated an exceptional aptitude for the sciences early in her academic journey, culminating in advanced degrees in virology and immunology. Her academic focus honed in on understanding the molecular mechanisms underlying viral infections, particularly influenza. This foundation provided her with the skills to innovate within vaccine development and immunization strategies. Her dedication to research began in St. Petersburg, Russia, where she laid the groundwork for her contributions to global virology.

PROFESSIONAL ENDEAVORS 💼

As a Senior Scientist at the Institute of Experimental Medicine and a professor at St. Petersburg State University, Yulia Desheva plays a pivotal role in advancing vaccine research. Her professional career spans leadership roles in virology, where she collaborates with global institutions like Academia Sinica in Taiwan. She is a valued member of the International Society for Influenza and Other Respiratory Virus Diseases (ISIRV) and contributes to scientific journals as a reviewer for Virology Journal, Journal of Infection and Public Health, and more.

CONTRIBUTIONS AND RESEARCH FOCUS ON IMMUNOLOGY🧪

Desheva’s groundbreaking work centers on vaccine development and viral-bacterial interactions. Her achievements include:

  • Development of live influenza vaccines tailored for high-risk individuals.
  • Creation and evaluation of mucosal vaccines addressing viral-bacterial infections and COVID-19.
  • Studying neuraminidase antibodies to advance immunization efficacy.
    Her innovative approach to developing vaccines for avian influenza viruses has positioned her as a leader in the field. Additionally, her research focuses on reducing bacterial complications arising from influenza infections through novel vaccine designs.

IMPACT AND INFLUENCE 🌍

Yulia Desheva's contributions extend beyond her laboratory to impact global public health. Her research has:

  • Enhanced vaccine accessibility for high-risk populations.
  • Influenced global strategies for managing pandemics and viral outbreaks.
  • Strengthened scientific collaboration across international borders.

Her role as a mentor has also nurtured the next generation of scientists, ensuring her legacy within virology and immunology.

ACADEMIC CITATIONS 📚

  • Books Published: 2
  • Peer-Reviewed Articles: 54 (published in SCI and Scopus-indexed journals)
  • Citation Index: 10

These metrics reflect her dedication to advancing scientific knowledge in virology and vaccine development.

LEGACY AND FUTURE CONTRIBUTIONS 🚀

With 20 patents to her name and numerous ongoing research projects, Yulia Desheva is poised to continue driving innovations in vaccine science. Her collaborative work with global institutions ensures her contributions will remain at the forefront of addressing emerging infectious diseases. She is committed to creating safer and more effective vaccines for future generations, cementing her legacy as a pioneer in immunology.

HIGHLIGHTS OF PROFESSIONAL ACHIEVEMENTS 🌟

  • Patents: 20
  • Completed/Ongoing Projects: 20
  • Editorial Roles: Reviewer for leading journals in virology and public health.
  • International Collaborations: Academia Sinica, Taiwan.

Desheva’s relentless pursuit of innovation and her interdisciplinary approach continue to inspire advancements in science and medicine.

NOTABLE PUBLICATIONS 📑

"Pilot Study Results on Antibodies to the S- and N-Proteins of SARS-CoV-2 in Paired Sera from COVID-19 Patients with Varying Severity

  • Authors: Desheva, Y. , Lerner, A. , Shvedova, T. , Leontieva, G. , Suvorov, A.
  • Journal: Antibodies
  • Year: 2023

"Establishment of a Pseudovirus Platform for Neuraminidase Inhibiting Antibody Analysis

  • Authors: Desheva, Y. , Petkova, N. , Losev, I. , Chao, Y.-C. , Tsai, C.-H.
  • Journal: International Journal of Molecular Sciences
  • Year: 2023

"Immune Response and Laboratory markers in the Spectrum of Severity of COVID-19

  • Authors: Desheva, Y.A. , Shvedova, T.N. , Kudar, P.А. , Petrachkova, D.S. , Lerner, A.A.
  • Journal: Medicine Academic Journal
  • Year: 2023

"Antigenic Characterization of Neuraminidase of Influenza A/H7N9 Viruses Isolated in Different Years

  • Authors: Desheva, Y. , Losev, I. , Petkova, N. , Tsai, C.-H. , Chao, Y.-C.
  • Journal: Pharmaceuticals
  • Year: 2022

"Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice

  • Authors: Desheva, Y. , Leontieva, G. , Kramskaya, T. , Kudar, P. , Suvorov, A.
  • Journal: Microorganisms
  • Year: 2022

Anish Maskey | Staphylococcus Aureus | Best Researcher Award

Dr. Anish Maskey | Staphylococcus Aureus | Best Researcher Award

New York Medical College | United States

Author Profile

Scopus

Orcid ID

Google Scholar

🌟 Dr. Anish R. Maskey, Ph.D. - Postdoctoral Fellow and Immunology Innovator

📚 EARLY ACADEMIC PURSUITS

Dr. Anish R. Maskey's academic journey began in Kathmandu, Nepal, where he earned a Bachelor of Science in 2016 from the Institute of Medicine. With a robust foundation in science, he pursued a Ph.D. in Pathology, Microbiology, and Immunology at New York Medical College, achieving an impressive CGPA of 3.75/4. His early education set the stage for a distinguished career in immunology, preparing him to tackle complex health challenges with innovative research approaches.

🧪 PROFESSIONAL ENDEAVORS

Currently a Postdoctoral Fellow in the Department of Pathology, Microbiology, and Immunology at New York Medical College, Dr. Maskey is mentored by Dr. Xiu-Min Li and focuses on pioneering research in immunology. His professional roles have spanned several collaborative and high-impact projects, including co-investigating clinical biomarker studies and leading efforts in immuno-oncology research related to chronic inflammatory and infectious diseases. Dr. Maskey’s work is characterized by his adept handling of sophisticated scientific techniques and a commitment to developing therapeutic strategies for challenging medical conditions.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON STAPHYLOCOCCUS AUREUS

Dr. Maskey's research contributions are extensive, with key focuses including:

  • B and T Cell Immunology: He has a deep-rooted expertise in investigating immune responses, particularly in relation to B and T cell functions in chronic inflammatory diseases and immuno-oncology.
  • Biomarker Studies in Allergy and Inflammation: His work on Traditional Chinese Medicine (TCM) involves understanding immune response markers in allergic diseases, the role of cytokines, and immune regulation, potentially offering new therapies for conditions such as eczema and food allergies.
  • Natural Compounds Against Antibiotic-Resistant Bacteria: In his role as Co-Principal Investigator, he has advanced research into natural compounds to combat antibiotic-resistant Staphylococcus aureus in both murine and humanized models.
  • Nanoparticle Immunotherapy: Dr. Maskey's study of berberine nanoparticles is pivotal in food allergy research, exploring mechanisms to suppress IgE-mediated allergic responses.

🌍 IMPACT AND INFLUENCE

Dr. Maskey's influence extends beyond the lab. His dedication to innovative research has earned him recognition through numerous awards, such as the AAAAI Ph.D. Travel Scholarships (2022-2024), the ASBMB Travel Award, and commendations for his scientific presentations. His involvement in conferences has facilitated cross-border collaborations, particularly between the U.S., India, and China, emphasizing his commitment to global health solutions. He is actively involved with organizations like the American Society for Microbiology and the American Academy of Allergy, Asthma, and Immunology, reflecting his dedication to community and professional engagement in the immunology field.

📈 ACADEMIC CITATIONS AND PUBLICATIONS

With his research published in high-impact journals, Dr. Maskey's contributions to immunology are recognized and respected. He has authored numerous papers and serves as a peer reviewer for journals like The FASEB Journal, Cell Press, and Dove Medical Press. His scholarly output includes first-author publications, institutional presentations, and national conference contributions, underscoring his commitment to advancing immunology research.

🏅 HONORS & AWARDS

  • AAAAI Ph.D. Travel Scholarship (2022-2024)
  • Outstanding Abstract Award at Touro Research Day (2024)
  • Science in a Flash Runner-Up by ASBMB (2022)
  • Outstanding Scientific Poster at MIT's Future of Health Technology Summit (2019)

🌐 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Maskey’s legacy in immunology is still unfolding, with his promising work paving the way for future advancements in immunotherapy and natural medicine. His research on TCM, immune biomarkers, and nanoparticle technology is expected to yield novel treatment methods for allergies, chronic inflammation, and infectious diseases. Additionally, his role as a mentor to young scientists and his involvement in developing educational materials ensure his impact will resonate through future generations of researchers and clinicians.

🌠 FINAL NOTE

Dr. Anish R. Maskey embodies the spirit of a dedicated scientist and innovator, leveraging his expertise to improve human health. His work in immunology and microbiology is not only a testament to his skill but also his passion for creating lasting changes in medicine and science. With a promising future, Dr. Maskey continues to contribute meaningfully to the scientific community and inspire his peers and students alike.

📑 NOTABLE PUBLICATIONS 

"Berberine Inhibits the Inflammatory Response Induced by Staphylococcus aureus Isolated from Atopic Eczema Patients via the TNF-α/Inflammation/RAGE Pathways" 

  • Authors: Maskey, A.R. , Kopulos, D. , Kwan, M. , Geliebter, J. , Li, X.-M.
  • Journal: Cells
  • Year: 2024

"Preclinical Models of Atopic Dermatitis Suitable for Mechanistic and Therapeutic Investigations" 

  • Authors: Maskey, A.R. , Mo, X. , Li, X.-M.
  • Journal: Journal of Inflammation Research
  • Year: 2024

"The Efficacy & Molecular Mechanisms of a Terpenoid Compound Ganoderic Acid C1 on Corticosteroid-Resistant Neutrophilic Airway Inflammation: In vivo and in vitro Validation" 

  • Authors: Wang, Z.-Z. , Li, H. , Maskey, A.R. , Sampson, H.A. , Li, X.-M.
  • Journal: Journal of Inflammation Research
  • Year: 2024

"Sustained silencing peanut allergy by xanthopurpurin is associated with suppression of peripheral and bone marrow IgE-producing B cell" 

  • Authors: Yang, N. , Srivastava, K. , Chen, Y. , Zhan, J. , Li, X.-M.
  • Journal: Frontiers in Immunology
  • Year: 2024

"Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and active compound berberine associated with immunometabolism regulation" 

  • Authors: Yang, N. , Maskey, A.R. , Srivastava, K. , Sampson, H.A. , Li, X.-M.
  • Journal: Frontiers in Immunology
  • Year: 2023